Literature DB >> 4854

Inhibition of prostaglandin biosynthesis by sulphasalazine and its metabolites.

H O Collier, A A Francis, W J McDonald-Gibson, S A Saeed.   

Abstract

Sulphasalazine (SZ) inhibits prostaglandin (PG) biosynthesis in vitro with a potency comparable to that of aceylsalicylate. The metabolites of SZ, sulphapyridine and 5-aminosalicylic acid, were of considerably lower potency as inhibitors of PG biosynthesis in the synthetase preparations used. Th inhibition of prostaglandin production by SZ could at least partly account for the clinical utility of sulphasalazine in ulcerative colitis. Sulphapyridine may help to maintain inhibitory concentrations of SZ by restraining bacterial breakdown of the active drug.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4854     DOI: 10.1016/0090-6980(76)90145-3

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  16 in total

Review 1.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 2.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

3.  Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine, codeine phosphate and prednisolone.

Authors:  P R Smith; D J Dawson; C H Swan
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

Review 4.  Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.

Authors:  Ashwin N Ananthakrishnan; Tamara Donaldson; Karen Lasch; Vijay Yajnik
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

5.  Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.

Authors:  K Hillier; P J Mason; S Pacheco; C L Smith
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

6.  Do prostaglandins cause gastrointestinal mucosal injury?

Authors:  M G Northway; D O Castell
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

7.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

Authors:  K Lauritsen; J Hansen; P Bytzer; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

Review 8.  Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes.

Authors:  Nielsen Q Fernandez-Becker; Alan C Moss
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2.

Authors:  E Goldin; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

10.  Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.

Authors:  D S Rampton; G E Sladen; L J Youlten
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.